Related Experiment Video
Updated: Jun 4, 2025

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
Genetic modulation of RNA splicing rescues BRCA2 function in mutant cells
Beatriz Anjo Lima1, Ana Carolina Pais1, Juliette Dupont2
1Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal.
Abstract:
Variants in the hereditary cancer-associated BRCA1 and BRCA2 genes can alter RNA splicing, producing transcripts that encode internally truncated yet potentially functional proteins. However, few studies have quantitatively analyzed variant-specific splicing isoforms. Here, we investigated cells heterozygous and homozygous for the BRCA2:c.681+5G>C variant. Using droplet digital RT-PCR, we identified two variant-specific mRNA isoforms. The predominant transcript is out-of-frame, contains a premature termination codon, and is degraded via the nonsense-mediated mRNA decay pathway. In addition, we detected a novel minor isoform encoding an internally truncated protein lacking non-essential domains. Homozygous mutant cells expressed low levels of BRCA2 protein and were defective in DNA repair. Using CRISPR-Cas9 gene editing, we induced the production of in-frame transcripts in mutant cells, which resulted in increased protein expression, enhanced RAD51 focus formation, and reduced chromosomal breaks after exposure to genotoxic agents. Our findings highlight the therapeutic potential of splicing modulation to restore BRCA2 function in mutant cells, offering a promising strategy to prevent cancer development.
Insights
Researchers explored how a BRCA2 gene variant affects RNA splicing, finding it produces truncated proteins. Modulating splicing restored BRCA2 function, offering a potential cancer prevention strategy.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- Hereditary cancer is often linked to mutations in BRCA1 and BRCA2 genes.
- Gene variants can disrupt RNA splicing, leading to truncated proteins.
- Quantitative analysis of variant-specific splicing isoforms is limited.
Purpose of the Study:
- To investigate the splicing consequences of the BRCA2:c.681+5G>C variant.
- To analyze the functional impact of variant-specific BRCA2 isoforms on DNA repair.
- To explore therapeutic strategies for restoring BRCA2 function through splicing modulation.
Main Methods:
- Droplet digital RT-PCR was used to identify and quantify mRNA isoforms.
- CRISPR-Cas9 gene editing was employed to induce in-frame transcripts.
- DNA repair capacity was assessed by measuring RAD51 focus formation and chromosomal breaks.
Main Results:
- Two variant-specific mRNA isoforms were identified for BRCA2:c.681+5G>C.
- The predominant isoform was out-of-frame, leading to nonsense-mediated decay.
- Homozygous cells showed reduced BRCA2 protein, DNA repair defects, and increased chromosomal instability.
- CRISPR-Cas9 editing restored in-frame transcripts, increasing protein levels and DNA repair efficiency.
Conclusions:
- The BRCA2:c.681+5G>C variant significantly impacts RNA splicing and protein function.
- Splicing modulation represents a promising therapeutic approach to restore BRCA2 function.
- Targeting splicing defects could offer a novel strategy for hereditary cancer prevention.
Related Concept Videos
RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Stability
What is Gene Expression?
Regulation of Expression at Multiple Steps

